Browsing by Author "Vives Armengol, Joaquim"
Now showing items 1-11 of 11
-
A pilot study of circulating levels of TGF-β1 and TGF-β2 as biomarkers of bone healing in patients with non-hypertrophic pseudoarthrosis of long bones
Chaverri, Daniel; Vivas Pradillo, Daniel; Gallardo-Villares, Santiago; Granell-Escobar, Fernando; Pinto, Javier A.; Vives Armengol, Joaquim (Elsevier, 2022-06) -
Adapting Cord Blood Collection and Banking Standard Operating Procedures for HLA-Homozygous Induced Pluripotent Stem Cells Production and Banking for Clinical Application
Vives Armengol, Joaquim; Casaroli-Marano, Ricardo P; Gomez, Susana G; Rodríguez Gómez, Luciano; Edel, Michael J; Querol Giner, Sergi; Alvarez-Palomo, Belén (MDPI, 2019-04-08) -
Characterization of a Cytomegalovirus-Specific T Lymphocyte Product Obtained Through a Rapid and Scalable Production Process for Use in Adoptive Immunotherapy
Grau Vorster, Marta; Lopez Montañes, Maria; Canto Puig, Ester; Vives Armengol, Joaquim; Oliver-Vila, Irene; Barba Suñol, Pere; Rudilla Salvador, Francesc (Frontiers Media, 2020-02-25) -
Compliance in Non-Clinical Development of Cell-, Gene-, and Tissue-Based Medicines: Good Practice for Better Therapies
López Navas, Luis; Sílvia Torrents; Sanchez-Pernaute, Rosario; Vives Armengol, Joaquim (Oxford University Press, 2022-08) -
Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton’s Jelly
Grau Vorster, Marta; Rodríguez Gómez, Luciano; Mazo Barbara, Anna del; Clementine, Mirabel; Ortega Blanco, Margarita; Codinach Creus, Margarita; Vives Armengol, Joaquim (MDPI, 2019-05-21) -
Osteogenic commitment of Wharton’s jelly mesenchymal stromal cells: mechanisms and implications for bioprocess development and clinical application
Cabrera Perez, Raquel; Monguió-Tortajada, Marta; Gámez-Valero, Ana; Rojas-Márquez, Raquel; Borràs, Francesc Enric; Roura, Santiago; Vives Armengol, Joaquim (BMC, 2019-11-28) -
Preclinical Development of a Therapy for Chronic Traumatic Spinal Cord Injury in Rats Using Human Wharton’s Jelly Mesenchymal Stromal Cells: Proof of Concept and Regulatory Compliance
Vives Armengol, Joaquim; Hernandez, Joaquim; Clementine, Mirabel; Puigdomenech-Poch, Maria; Romeo-Guitart, David; Marmolejo Martínez-Artesero, Sara; Cabrera Perez, Raquel (MDPI, 2022-07-08) -
The Quality Management Ecosystem in Cell Therapy in Catalonia (Spain): An Opportunity for Integrating Standards and Streamlining Quality Compliance
Vives Armengol, Joaquim; Sòria, Maria Glòria; McGrath, Eoin; Magri, Mara (MDPI, 2022-07-05) -
Towards the standardization of methods of tissue processing for the isolation of mesenchymal stromal cells for clinical use
García-Muñoz, Elisabeth; Vives Armengol, Joaquim (Springer, 2021-06) -
Transitioning From Preclinical Evidence to Advanced Therapy Medicinal Product: A Spanish Experience
Gastelurrutia, Paloma; Prat-Vidal, Cristina; Vives Armengol, Joaquim; Coll, Ruth; Bayes-Genis, Antoni; Gálvez-Montón, Carolina (Frontiers Media, 2021-02-04) -
Wharton’s Jelly Mesenchymal Stromal Cells and Derived Extracellular Vesicles as Post-Myocardial Infarction Therapeutic Toolkit: An Experienced View
Muñoz-Domínguez, Noelia; Roura, Santiago; Prat-Vidal, Cristina; Vives Armengol, Joaquim (MDPI, 2021-08-26)